What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001592614
Total reported value
$209.0M
$209.0M
95 檔
17.0%
As reported in its official Q4 2024 Form 13F filing, Dempze Nancy E's tracked investment portfolio stood at $209.0M with 95 total positions.
During Q4 2024, Dempze Nancy E's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
In terms of portfolio concentration, the top 5 core holdings (including NVDA, AAPL, GOOGL) accounted for 17.0% of total reported equity market value during Q4 2024.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NVDA | Nvidia CORP | Stock-Tech | 5.18% | -0.15% | -5.52% | |
| 2 | AAPL | Apple Inc | Stock-Tech | 4.49% | -0.01% | -0.29% | |
| 3 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 3.73% | +0.29% | +4.31% | |
| 4 | MSFT | Microsoft CORP | Stock-Tech | 3.71% | -0.28% | +5.93% | |
| 5 | MA | Mastercard Inc - A | Stock-Financials | 3.36% | -0.23% | -0.31% | |
| 6 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 3.32% | -0.01% | +2.02% | |
| 7 | FISV | Fiserv Inc | Stock-Other | 3.24% | -0.40% | -3.00% | |
| 8 | ADP | Automatic Data Processing | Stock-Tech | 2.96% | -0.07% | -1.46% | |
| 9 | ADI | Analog Devices Inc | Stock-Tech | 2.80% | +0.08% | +2.23% | |
| 10 | ABT | Abbott Laboratories | Stock-Healthcare | 2.72% | -0.66% | +4.68% | |
| 11 | HD | Home Depot Inc | Stock-Consumer Disc | 2.67% | -0.13% | +1.32% | |
| 12 | TJX | Tjx Companies Inc | Stock-Consumer Disc | 2.53% | -0.56% | +4.29% | |
| 13 | DHR | Danaher CORP | Stock-Healthcare | 2.43% | -0.41% | +4.78% | |
| 14 | PG | Procter & Gamble Co/the | Stock-Consumer Staples | 2.31% | -0.20% | -0.79% | |
| 15 | ROK | Rockwell Automation Inc | Stock-Industrials | 2.25% | +0.44% | +1.49% | |
| 16 | UNH | Unitedhealth Group Inc | Stock-Healthcare | 2.24% | -0.43% | +0.67% | |
| 17 | ATR | Aptargroup Inc | Stock-Healthcare | 2.11% | -0.36% | +0.94% | |
| 18 | JNJ | Johnson & Johnson | Stock-Healthcare | 2.10% | -0.32% | -2.90% | |
| 19 | SBGSY | Schneider Elect Se-unsp Adr | Stock-Other | 2.07% | +0.15% | +12.08% | |
| 20 | AMD | Advanced Micro Devices | Stock-Tech | 2.04% | +2.84% | +4.51% | |
| 21 | RTX | Rtx CORP | Stock-Industrials | 2.01% | -0.55% | -2.26% | |
| 22 | XYL | Xylem Inc | Stock-Industrials | 1.73% | -0.23% | +0.34% | |
| 23 | CNI | Canadian Natl Railway Co | Stock-Industrials | 1.71% | -0.01% | -5.90% | |
| 24 | V | Visa Inc-class A Shares | Stock-Financials | 1.60% | -0.05% | — | |
| 25 | VDIGX | Vanguard Dividend Growth-inv | Stock-Other | 1.51% | -0.04% | — | |
| 26 | CARR | Carrier Global CORP | Stock-Industrials | 1.48% | -0.20% | +20.48% | |
| 27 | VRTX | Vertex Pharmaceuticals Inc | Stock-Healthcare | 1.41% | +0.05% | +24.81% | |
| 28 | ARIMX | Amg Rr Smid Val-i | Stock-Other | 1.32% | -0.08% | +12.80% | |
| 29 | MKC | Mccormick & Co-non Vtg Shrs | Stock-Consumer Staples | 1.16% | — | +28.45% | |
| 30 | BALL | Ball CORP | Stock-Consumer Disc | 1.10% | — | +8.14% | |
| 31 | MS | Morgan Stanley | Stock-Financials | 1.09% | — | — | |
| 32 | GQGIX | Gqg Part Emerg Mkts Eq-inst | Stock-Other | 1.07% | -0.15% | — | |
| 33 | NSRGY | Nestle Sa-spons Adr | Stock-Other | 0.99% | — | -14.59% | |
| 34 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.95% | +0.60% | -19.47% | |
| 35 | GPN | Global Payments Inc | Stock-Industrials | 0.94% | -0.09% | -3.33% | |
| 36 | BDX | Becton Dickinson And Co | Stock-Healthcare | 0.92% | — | -10.02% | |
| 37 | VGSTX | Vanguard Star Fund-inv | Stock-Other | 0.90% | -0.03% | — | |
| 38 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 0.80% | -0.08% | -2.85% | |
| 39 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 0.79% | — | — | |
| 40 | CVX | Chevron CORP | Stock-Energy | 0.78% | -0.46% | +2.84% | |
| 41 | VIG | Vanguard Dividend Apprec ETF | ETF-Other | 0.70% | -0.03% | — | |
| 42 | ABBV | Abbvie Inc | Stock-Healthcare | 0.70% | -0.04% | -1.02% | |
| 43 | JPM | Jpmorgan Chase & Co | Stock-Financials | 0.69% | -0.02% | -1.38% | |
| 44 | AIG | American International Group | Stock-Financials | 0.67% | -0.12% | EXIT | |
| 45 | WMS | Advanced Drainage Systems In | Stock-Industrials | 0.67% | -0.04% | -13.04% | |
| 46 | OAKIX | Oakmark International-inv | Stock-Other | 0.63% | -0.02% | — | |
| 47 | WD | Walker & Dunlop Inc | Stock-Other | 0.62% | -0.05% | -11.20% | |
| 48 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.59% | -0.02% | — | |
| 49 | TRLGX | T Rowe Pr Lrg Cap Grw-i | Stock-Other | 0.55% | -0.19% | +61.72% | |
| 50 | GOOG | Alphabet Inc-cl C | Stock-Comm Services | 0.50% | +0.04% | — |
According to official SEC Form 13F filings, Dempze Nancy E reported a total U.S. public equity portfolio value of $209.0M across 95 disclosed positions in Q4 2024.
During Q4 2024, Dempze Nancy E's top holdings by market value included NVDA (5.2%)、AAPL (4.5%)、GOOGL (3.7%). The largest single position, NVDA, represented 5.2% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In Q4 2024, Dempze Nancy E made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.